Find Federal Grants
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-159
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-160
National Institutes of Health · PAR-23-098
Maternal Health Research Collaborative for Minority-Serving Institutions (MH-RC-MSI) Coordinating Center (CC)
Health Resources and Services Administration · HRSA-23-113
Maternal Health Research Collaborative for Minority-Serving Institutions (MH-RC-MSI) Research Centers (RCs)
Health Resources and Services Administration · HRSA-23-112
Health Resources and Services Administration · HRSA-23-108
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)
Health Resources and Services Administration · HRSA-23-127
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites
Health Resources and Services Administration · HRSA-23-126
CENTERS FOR DISEASE CONTROL CSTLTS · CDC-RFA-TO23-2304
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health · PAR-23-155
PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States (EHE) Component C mpox Supplement
Centers for Disease Control - NCHHSTP · CDC-RFA-PS20-20100101SUPP23
Forest Service · USDA-FS-2023-UCF-IRA-01
Essentials for Childhood (EfC): Preventing Adverse Childhood Experiences through Data to Action
Centers for Disease Control - NCIPC · CDC-RFA-CE-23-0005
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-163
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-119
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-154
Health Resources and Services Administration · HRSA-23-081
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
National Institutes of Health · PAR-23-158
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-23-157
Lowlands Health Activity
Ethiopia USAID-Addis Ababa · 72066323RFA00007